Cargando…

Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disease. Ferroptosis plays a critical role in neurodegenerative diseases. Nuclear factor E2-related factor 2 (Nrf2) is considered an important factor in ferroptosis. Studies have demonstrated that salidroside has a potential therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sixia, xie, Zeping, Pei, Tingting, zeng, Yi, Xiong, Qiaowu, Wei, Hui, Wang, Yong, Cheng, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254541/
https://www.ncbi.nlm.nih.gov/pubmed/35787281
http://dx.doi.org/10.1186/s13020-022-00634-3
_version_ 1784740722828640256
author Yang, Sixia
xie, Zeping
Pei, Tingting
zeng, Yi
Xiong, Qiaowu
Wei, Hui
Wang, Yong
Cheng, Weidong
author_facet Yang, Sixia
xie, Zeping
Pei, Tingting
zeng, Yi
Xiong, Qiaowu
Wei, Hui
Wang, Yong
Cheng, Weidong
author_sort Yang, Sixia
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disease. Ferroptosis plays a critical role in neurodegenerative diseases. Nuclear factor E2-related factor 2 (Nrf2) is considered an important factor in ferroptosis. Studies have demonstrated that salidroside has a potential therapeutic effect on AD. The intrinsic effect of salidroside on ferroptosis is unclear. The purpose of this study was to investigate the protective effects and pharmacological mechanisms of salidroside on alleviating neuronal ferroptosis in Aβ(1−42)-induced AD mice and glutamate-injured HT22 cells. METHODS: HT22 cells were injured by glutamate (Glu), HT22 cells transfected with siRNA Nrf2, and Aβ(1−42)-induced WT and Nrf2(−/−)AD mice were treated with salidroside. The mitochondria ultrastructure, intracellular Fe(2+), reactive oxygen species, mitochondrial membrane potential, and lipid peroxidation of HT22 cells were detected. Malondialdehyde, reduced glutathione, oxidized glutathione disulfide, and superoxide dismutase were measured. The novel object recognition test, Y-maze, and open field test were used to investigate the protective effects of salidroside on Aβ(1−42)-induced WT and Nrf2(−/−)AD mice. The protein expressions of PTGS2, GPX4, Nrf2, and HO1 in the hippocampus were investigated by Western blot. RESULTS: Salidroside increased the cell viability and the level of MMP of Glu-injured HT22 cells, reduced the level of lipid peroxidation and ROS, and increased GPX4 and SLC7A11 protein expressions. These changes were not observed in siRNA Nrf2 transfected HT22 cells. Salidroside improved the ultrastructural changes in mitochondria of HT22 cells and Aβ(1−42)-induced AD mice, but not in Aβ(1−42)-induced Nrf2(−/−)AD mice. Salidroside increased protein expression levels of GPX4, HO1, and NQO1 and decreased protein expression of PTGS2 in Aβ(1−42)-induced AD mice but not in Aβ(1−42)-induced Nrf2(−/−)AD mice. CONCLUSIONS: Salidroside plays a neuroprotective role by inhibiting neuronal ferroptosis in Aβ(1−42)-induced AD mice and Glu-injured HT22 cells, and its mechanism is related to activation of the Nrf2/HO1 signaling pathway. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9254541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92545412022-07-06 Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells Yang, Sixia xie, Zeping Pei, Tingting zeng, Yi Xiong, Qiaowu Wei, Hui Wang, Yong Cheng, Weidong Chin Med Research BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disease. Ferroptosis plays a critical role in neurodegenerative diseases. Nuclear factor E2-related factor 2 (Nrf2) is considered an important factor in ferroptosis. Studies have demonstrated that salidroside has a potential therapeutic effect on AD. The intrinsic effect of salidroside on ferroptosis is unclear. The purpose of this study was to investigate the protective effects and pharmacological mechanisms of salidroside on alleviating neuronal ferroptosis in Aβ(1−42)-induced AD mice and glutamate-injured HT22 cells. METHODS: HT22 cells were injured by glutamate (Glu), HT22 cells transfected with siRNA Nrf2, and Aβ(1−42)-induced WT and Nrf2(−/−)AD mice were treated with salidroside. The mitochondria ultrastructure, intracellular Fe(2+), reactive oxygen species, mitochondrial membrane potential, and lipid peroxidation of HT22 cells were detected. Malondialdehyde, reduced glutathione, oxidized glutathione disulfide, and superoxide dismutase were measured. The novel object recognition test, Y-maze, and open field test were used to investigate the protective effects of salidroside on Aβ(1−42)-induced WT and Nrf2(−/−)AD mice. The protein expressions of PTGS2, GPX4, Nrf2, and HO1 in the hippocampus were investigated by Western blot. RESULTS: Salidroside increased the cell viability and the level of MMP of Glu-injured HT22 cells, reduced the level of lipid peroxidation and ROS, and increased GPX4 and SLC7A11 protein expressions. These changes were not observed in siRNA Nrf2 transfected HT22 cells. Salidroside improved the ultrastructural changes in mitochondria of HT22 cells and Aβ(1−42)-induced AD mice, but not in Aβ(1−42)-induced Nrf2(−/−)AD mice. Salidroside increased protein expression levels of GPX4, HO1, and NQO1 and decreased protein expression of PTGS2 in Aβ(1−42)-induced AD mice but not in Aβ(1−42)-induced Nrf2(−/−)AD mice. CONCLUSIONS: Salidroside plays a neuroprotective role by inhibiting neuronal ferroptosis in Aβ(1−42)-induced AD mice and Glu-injured HT22 cells, and its mechanism is related to activation of the Nrf2/HO1 signaling pathway. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-07-04 /pmc/articles/PMC9254541/ /pubmed/35787281 http://dx.doi.org/10.1186/s13020-022-00634-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Sixia
xie, Zeping
Pei, Tingting
zeng, Yi
Xiong, Qiaowu
Wei, Hui
Wang, Yong
Cheng, Weidong
Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title_full Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title_fullStr Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title_full_unstemmed Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title_short Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1-42)-induced Alzheimer’s disease mice and glutamate-injured HT22 cells
title_sort salidroside attenuates neuronal ferroptosis by activating the nrf2/ho1 signaling pathway in aβ(1-42)-induced alzheimer’s disease mice and glutamate-injured ht22 cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254541/
https://www.ncbi.nlm.nih.gov/pubmed/35787281
http://dx.doi.org/10.1186/s13020-022-00634-3
work_keys_str_mv AT yangsixia salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT xiezeping salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT peitingting salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT zengyi salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT xiongqiaowu salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT weihui salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT wangyong salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells
AT chengweidong salidrosideattenuatesneuronalferroptosisbyactivatingthenrf2ho1signalingpathwayinab142inducedalzheimersdiseasemiceandglutamateinjuredht22cells